13.5 C
Sunday, August 1, 2021
- Advertisement -


Clinical trials of Covaxin

DCGI Approves Phase II/III Clinical Trial Of Covaxin In The Age Group Of 2 To 18 Years

The DCGI has accorded permission to conduct the Phase II-III clinical trial of Covaxin in the age group of two to 18-years-old to the Hyderabad based manufacturer Bharat Biotech International Ltd (BBIL). The trials will be conducted in 525 health volunteers

Latest news

- Advertisement -
Support our mission of Independent Journalism on Patreon!